Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just caught the CHE earnings and man, this one stung. Stock got absolutely hammered - dropped like 15% after they reported Q4 numbers that missed on both earnings and revenue. Fourth quarter adjusted EPS came in at $6.42, down 6% year-over-year and beat expectations by a mile... in the wrong direction. Revenue was $639.3M, basically flat compared to last year but still missed consensus. The real problem though? Margins are getting crushed. Gross margin contracted almost 200 basis points, which is rough.
Breaking down the two main segments - VITAS (the hospice side) actually held up okay with revenues up 1.9%, but Roto-Rooter is the one struggling. Residential business down 3.1%, and you can see the weakness in water restoration dropping 10%. Commercial side managed slight gains but not enough to offset the residential drag. The company's also burning through cash - went from $178M to $74.5M in cash by year-end, partly because they bought back 400k shares.
What's interesting is management is trying to spin 2026 as a transition year. They're guiding for CHE revenue growth of 5.5% and adjusted EPS of $23.25-$24.25, but honestly that's below what consensus was expecting. The VITAS Medicare Cap situation in Florida seems to be a bigger headwind than they initially thought. If CHE can't stabilize margins and get Roto-Rooter growing again, this could trend lower. Holding pattern for now.